Trial · NCT07909876
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
NCT07909876, Not applicable, Not yet recruiting, Taipei Medical University WanFang Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Decision Support Tool for Common Surgical Fixations of Hip Fractures. Trials, record NCT07909876. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909876
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Decision Support Tool for Common Surgical Fixations of Hip Fractures
- NCT number
- NCT07909876
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 450 participants, estimated
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Conditions
- Hip Fracture Surgeries, High Risk Population of Hip Fractures, Decision Surrogate of Hip Fixations
- Interventions
- IDeA for Hip Fracture, Non-IDeA for hip fracture
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Knowledge of hip fracture surgery | From enrollment at baseline to one hour after treatment. | Five self-developed true and false questions regarding hip fracture surgeries. The minimum and maximum values are 0 and 5. Higher scores mean a better knowledge on hip fracture surgery. |
| Primary | Decision self-efficacy | From enrollment at baseline to one hour after treatment. | Decision self-efficacy will be measured using the Decision Self-Efficacy Scale (DSES) by Bunn H. and O'Connor A. (1996). The minimum and maximum values of the DSES are 0 and 44. Higher scores mean a stronger self-efficacy in making decision. |
| Primary | Decisional conflict | From enrollment at baseline to one hour after treatment. | Decisional conflict will be measured using the SURE scale that consists of four yes/no questions based on the Decisional Conflict Scale (DCS) by Ferron Parayre, A., Labrecque, M., Rousseau, M., Turcotte, S., \& Légaré, F. (2014). The minimum and maximum values of SURE are 0 and 4. Higher scores mean a lower decisional conflict. |
| Primary | Decisional satisfaction | From enrollment at baseline to one hour after treatment. | Decisional satisfaction will be measured using the Satisfaction with Decision (SWD) scale by Holmes-Rovner et al. (1996) and Wills \& Holmes-Rovner (2003). The minimum and maximum values of the SWD are 6 and 30. Higher scores mean a higher satisfaction in decision making. |
| Secondary | Style of decisional control | From enrollment at baseline to one hour after treatment. | Style of decisional control will be measured using the Control Preferences Scale (CPS) by Degner, L. F., Sloan, J. A., \& Venkatesh, P. (1997). The CPS is a categorical scale for different style of control preference without minimum or maximum values. |
| Secondary | Perceives in AI | One hour after treatment. | Perceives in AI will be measured using the tool that has been introduced in the AMAILED model by Kang, E., Chen, D., \& Chen, Y. (2022). This tool consists of two parts: trust and perceived usefulness of AI. The minimum and maximum values of perceives in AI are 7 and 35. Higher scores mean a higher trust or perceived usefulness of AI. |
| Secondary | Intention to use AI | One hour after treatment. | Intention to use AI will be measured using the tool that has been introduced in the AMAILED model by Kang, E., Chen, D., \& Chen, Y. (2022). The minimum and maximum values are 3 and 15. Higher scores mean a higher intention to use AI. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909876
GET https://conductscience.org/api/trials/v1/NCT07909876/registered